| Name | Title | Contact Details |
|---|---|---|
Daniel Apel |
Chief Financial Officer | Profile |
Elliott Blufer |
Assistant General Counsel | Profile |
Scott Phillips |
Director, Enterprise Systems and Compliance | Profile |
Patrick O`Brien |
General Counsel | Profile |
FFF Enterprises Inc is a Temecula, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.
Akcea Therapeutics is a development and commercialization company focused on helping patients with serious diseases. Our priority is to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize our products on a global basis. We are driven by knowing that patients depend on us. An affiliate of Ionis Pharmaceuticals and based in Kendall Square, Cambridge, Massachusetts, Akcea was founded with a robust portfolio of development-stage drugs covering multiple targets and disease states using advanced antisense therapeutics. Akcea is derived from the Greek word for value and worth. Something that has akcea (αξία) is not common, but precious and rare. Our name supports the value we are creating for physicians, patients and their families, and other key stakeholders as we seek to commercialize a robust portfolio of development-stage, advanced, antisense therapies for serious cardiometabolic lipid disorders. Our immediate focus is to drive our clinical programs forward through development to commercialization while building on the Isis standards of excellence.
TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions.
Genactis is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.